News Tesaro gets European approval on Zejula, set to challenge AZ Tesaro's PARP drug approved in wider ovarian cancer population
News MicroRNA diagnostic could be big advance in ovarian cancer AI blood test achieves very high accuracy and specificity for detecting ovarian cancer.
News Tesaro's Zejula primed for EU approval, battle with AZ EU regulators recommend PARP inhibitor Zejula
News Rubraca outshines rivals in ovarian cancer maintenance thera... Clovis' Rubraca, the drug showing significant benefits for all ovarian cancer patients in a maintenance setting – and better results than its rivals.
News AZ and Merck & Co ovarian cancer drug gets expanded US use FDA approves Lynparza's use in a wider group of women.
News Angle poised to take on US cancer diagnostics market Circulating tumour cell test could help select drug therapy.
News Praxis soars on rare childhood epilepsy trial data Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
